Nano Dimension Ltd. 8-K

What Happened

• Nano Dimension Ltd. announced on June 16, 2026 a press release providing additional information regarding its proposed business combination with Infinite Epigenetics, Inc. The company filed a Form 8‑K on June 17, 2026 (Item 7.01, Regulation FD Disclosure) and furnished the press release as Exhibit 99.1 to that filing.

Key Details

• Press release date: June 16, 2026.
• Form 8‑K filing date: June 17, 2026 (Regulation FD Disclosure, Item 7.01).
• Exhibit furnished: Exhibit 99.1 contains the press release with the additional information about the proposed business combination.
• The filing also includes the interactive cover page XBRL file (Exhibit 104).

Why It Matters

• This disclosure provides investors with updated, public information about Nano Dimension’s proposed business combination (merger/acquisition) with Infinite Epigenetics.
• Because it was made under Regulation FD, the company aimed to broadly disseminate the update to all investors at the same time.
• Investors should read the furnished press release and monitor Nano Dimension’s future SEC filings (e.g., definitive agreements, proxy statements or registration statements) for material terms, transaction structure, timing, and any financial impacts.